The Swiss Stock Exchange was trusting Tuesday morning in the first exchanges, without falling into recklessness. Investors kept a riveted eye on American customs duties, the other already turning to the next statement on the increase in the United States.
Chinese and American negotiators agreed to extend the truce in the trade war between the first two economies of the planet by three months. John Plassard, partner at Cité Gestion underlines, however, that it is the figures for CPI inflation in the United States (agenda for 2:30 p.m., editor’s note) that will constitute the central point of this session.
Donald Trump finally confirmed on Monday that he had not imposed a commercial barrier on yellow metal trading. “The measure serves the interests of the United States by avoiding disturbing the flows of gold,” explains Swissquote Ipek Ozkardeskaya at Swissquote.
At 9:11 am, the Swiss Market Index (SMI) scored 0.08% to 11,879.26 points, the Swiss Leader Index (SLI) 0.11% at 1981.55% and the Swiss Performance Index (SPI) 0.15% to 16.591.57 points. Of the 31 stars values, only seven get out of red.
The values of Luxury Richemont ( +1%) and Swatch (carrier +0.9%) led dance, without any particular indication. The Sonova hearing specialist (+0.7%) made a lot of noise for the launch of a new device, miniaturized and rechargeable.
The Nestlé dietary liner (+0.2%) that the overall progression was limpment.
Pharmaceutical heavy goods vehicles, on the other hand, were both on the wrong side of the bar. Novartis (-0.1%) limited damage, following study results on experimental treatment in immunology. The good rock lost 0.4%.
The red lantern returned to UBS (-0.9%), on the fundraising funds for an institutional investor. The ophthalmic giant Alcon retreated 0.2%, without any particular indication.
On the enlarged market, the Polypeptide pharmaceutical subcontractor appreciated 5.9%, after having tightened the corridor of its ambitions for the whole year. The Tecan laboratory equipment supplier (+13%) was flying, after having confirmed an expected access to the first half, but also launched an action buyback program.
The Komax (-14%) wiring machine manufacturer occupied the other end of the classification, which published a significant mid-term loss in place of a expected benefit. (Awp)